🔗 Permalink

Inventor profile of:

Thomas M. Folks

City:

Helotes, Texas

Country:

United States

Published Applications:

Last publication date:

2024-02-08

Top Assignees for applications by Thomas M. Folks

The entities that hold a legal rights for patent applications filed by inventor Folks Thomas M.:

The United States of America, as represented by the Secretary, Department of Health and Human Servic 4 Bethesda, MD United States
JOHNS HOPKINS UNIVERSITY 4 Baltimore, MD United States
The United States of America, as represented by the Secretary, Department of Health and Human Services 4 Washington, DC United States
The United States of America, as represented by the Secretary, Department of Health and Human 4 Bethesda, MD United States
The USA, as represented by the Secretary, Department of Health and Human Services 3 Bethesda, MD United States
The United States of America, as represented by the Secretary, Department of Health and Human Serv 2 Bethesda, MD United States
The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention 2 Washington, DC United States
The United States of America, as represented by the Secretary, Dept. of Health and Human Service 1 Bethesda, MD United States
The United States of America as Represented by the Department of Health and Human Services 1 Washington, DC United States
The Government of the United States of America as Represented by the Secretary of the Department of 1 Atlanta, GA United States
The Government of the U.S.A as Represented by the Secretary of the Department of He 1 Atlanta, GA United States

Recent patent applications by Folks Thomas M.

Thomas M. Folks from Helotes, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-02-08

US20240041906A1

Human necessities

PRE-EXPOSURE PROPHYLAXIS OF HIV INFECTIONS

#2 | 2023-12-21

US20230405027A1

Human necessities

INHIBITION OF HIV INFECTION THROUGH CHEMOPROPHYLAXIS

#3 | 2023-12-07

US20230390313A1

Human necessities

METHODS OF PREVENTING HIV INFECTIONS IN HUMANS

#4 | 2022-01-20

US20220016141A1

Human necessities

METHODS OF PREVENTING HIV INFECTIONS IN HUMANS

#5 | 2022-01-20

US20220016140A1

Human necessities

INHIBITION OF HIV INFECTION THROUGH CHEMOPROPHYLAXIS

#6 | 2022-01-20

US20220016139A1

Human necessities

METHODS OF INHIBITING HIV INFECTIONS BY PRE-EXPOSURE PROPHYLAXIS

#7 | 2021-12-30

US20210401858A1

Human necessities

PRE-EXPOSURE PROPHYLAXIS OF HIV INFECTIONS

#8 | 2020-06-25

US20200197421A1

Human necessities

METHODS OF INHIBITING HIV INFECTIONS BY PRE-EXPOSURE PROPHYLAXIS

#9 | 2020-06-25

US20200197420A1

Human necessities

METHODS OF PREVENTING HIV INFECTIONS IN HUMANS

#10 | 2020-06-25

US20200197419A1

Human necessities

PRE-EXPOSURE PROPHYLAXIS OF HIV INFECTIONS

#11 | 2019-09-05

US20190269708A1

Human necessities

INHIBITION OF HIV INFECTION THROUGH CHEMOPROPHYLAXIS

#12 | 2018-07-12

US20180193366A1

Human necessities

Inhibition of HIV infection through chemoprophylaxis

#13 | 2017-05-25

US20170143745A1

Human necessities

Inhibition of HIV infection through chemoprophylaxis

#14 | 2015-10-01

US20150272972A1

Human necessities

Inhibition of HIV infection through chemoprophyalxis

#15 | 2014-07-03

US20140186383A1

Chemistry; metallurgy

NOVEL SIMIAN T-CELL LYMPHOTROPIC VIRUS

#16 | 2014-03-20

US20140080121A1

Chemistry; metallurgy

Primate T-lymphotropic viruses

#17 | 2010-12-16

US20100317034A1

Chemistry; metallurgy

Primate T-lymphotropic viruses

#18 | 2008-11-27

US20080292657A1

Chemistry; metallurgy

Primate T-lymphotropic viruses

#19 | 2007-11-15

US20070265227A1

Human necessities

Inhibition of HIV infection through chemoprophylaxis

InventorID:

694953 ⎘